Commentary on: Clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophreniaMELTZER, Herbert Y.Psychopharmacologia. 2002, Vol 163, Num 1, pp 1-3, issn 0033-3158Article

Putting metabolic side effects into perspective : Risks versus benefits of atypical antipsychoticsMELTZER, Herbert Y.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 27, pp 35-39Conference Paper

A genetic locus in 7p12.2 associated with treatment resistant schizophreniaJIANG LI; MELTZER, Herbert Y.Schizophrenia research. 2014, Vol 159, Num 2-3, pp 333-339, issn 0920-9964, 7 p.Article

Serotonergic Mechanisms as Targets for Existing and Novel AntipsychoticsMELTZER, Herbert Y.Handbook of experimental pharmacology. 2012, Vol 212, pp 87-124, issn 0171-2004, 38 p.Article

Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic eraBASU, Anirban; MELTZER, Herbert Y.Schizophrenia research. 2006, Vol 86, Num 1-3, pp 99-109, issn 0920-9964, 11 p.Article

Treatment-Resistant Schizophrenia: The Importance of Early Detection and Treatment. SymposiumMELTZER, Herbert Y; PRINGUEY, Dominique.Journal of clinical psychopharmacology. 1998, Vol 18, Num 2, issn 0271-0749, 25 p., SUP1Conference Proceedings

The InterSePT suicide scale for prediction of imminent suicidal behaviorsAYER, David W; JAYATHILAKE, Karu; MELTZER, Herbert Y et al.Psychiatry research (Print). 2008, Vol 161, Num 1, pp 87-96, issn 0165-1781, 10 p.Article

Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release : Role of 5-HT_1A receptor agonismICHIKAWA, Junji; JIN DAI; MELTZER, Herbert Y et al.Brain research. 2005, Vol 1049, Num 2, pp 182-190, issn 0006-8993, 9 p.Article

COMT vall08/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophreniaWOODWARD, Neil D; JAYATHILAKE, Karu; MELTZER, Herbert Y et al.Schizophrenia research. 2007, Vol 90, Num 1-3, pp 86-96, issn 0920-9964, 11 p.Article

Clozapine-induced weight gain predicts improvement in psychopathologyMELTZER, Herbert Y; PERRY, Edward; JAYATHILAKE, Karuna et al.Schizophrenia research. 2003, Vol 59, Num 1, pp 19-27, issn 0920-9964, 9 p.Article

Reducing suicide risk in schizophrenia: Focus on the role of clozapineMELTZER, Herbert Y; ANAND, Ravi; ALPHS, Larry et al.CNS drugs. 2000, Vol 14, Num 5, pp 355-365, issn 1172-7047Article

Determinants of work outcome in schizophrenia and schizoaffective disorder: Role of cognitive functionKANEDA, Yasuhiro; JAYATHILAK, Karuna; MELTZER, Herbert Y et al.Psychiatry research (Print). 2009, Vol 169, Num 2, pp 178-179, issn 0165-1781, 2 p.Article

Does stimulation of 5-HT_1A receptors improve cognition in schizophrenia?MELTZER, Herbert Y; SUMIYOSHI, Tomiki.Behavioural brain research. 2008, Vol 195, Num 1, pp 98-102, issn 0166-4328, 5 p.Article

A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophreniaSUMIYOSHI, Tomiki; JAYATHILAKE, Karu; MELTZER, Herbert Y et al.Schizophrenia research. 2003, Vol 62, Num 1-2, pp 65-72, issn 0920-9964, 8 p.Article

DOI, a 5-HT_2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine releaseICHIKAWA, Junji; JIN DAI; MELTZER, Herbert Y et al.Brain research. 2001, Vol 907, Num 1-2, pp 151-155, issn 0006-8993Article

The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophreniaMELTZER, Herbert Y; LEE, Myung A; JAYATHILAKE, Karuna et al.Neuropsychopharmacology (New York, NY). 2001, Vol 24, Num 3, pp 278-290, issn 0893-133XArticle

Interaction of mGlu_2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated ratsHORIGUCHI, Masakuni; HUANG, Mei; MELTZER, Herbert Y et al.Psychopharmacologia. 2011, Vol 217, Num 1, pp 13-24, issn 0033-3158, 12 p.Article

Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behaviorKIM, Chan-Hyung; JAYATHILAKE, Karu; MELTZER, Herbert Y et al.Schizophrenia research. 2003, Vol 60, Num 1, pp 71-80, issn 0920-9964, 10 p.Article

The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophreniaSUMIYOSHI, Tomiki; JAYATHILAKE, Karu; MELTZER, Herbert Y et al.Schizophrenia research. 2003, Vol 59, Num 1, pp 7-16, issn 0920-9964, 10 p.Article

5-HT_1A receptor dysfunction in Female patients with schizophreniaLEE, Myung A; MELTZER, Herbert Y.Biological psychiatry (1969). 2001, Vol 50, Num 10, pp 758-766, issn 0006-3223Article

Melperone in the treatment of neuroleptic-resistant schizophreniaMELTZER, Herbert Y; SUMIYOSHI, Tomiki; JAYATHILAKE, Karu et al.Psychiatry research. 2001, Vol 105, Num 3, pp 201-209, issn 0165-1781Article

Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: Relationship to plasma cortisol concentrationLEE, Myung; JAYATHILAKE, Karu; JIN DAI et al.Psychiatry research (Print). 2011, Vol 185, Num 3, pp 328-333, issn 0165-1781, 6 p.Article

The cognitive efficacy of atypical antipsychotics in schizophreniaSHARMA, T; MOCKLER, D.Journal of clinical psychopharmacology. 1998, Vol 18, Num 2, pp 12S-19S, issn 0271-0749, SUP1Conference Paper

Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanismsPRUS, Adam J; BAKER, Lisa E; MELTZER, Herbert Y et al.Pharmacology, biochemistry and behavior. 2004, Vol 77, Num 2, pp 199-208, issn 0091-3057, 10 p.Article

Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and miceZHU LI; KIM, Chan H; ICHIKAWA, Junji et al.Pharmacology, biochemistry and behavior. 2003, Vol 75, Num 2, pp 335-340, issn 0091-3057, 6 p.Article